<< 1 >>
Top Biotechnology Blogs
Share the Top Biotechnology Blogs on
bio-technology « WordPress.com Tag Feed
Shewanella bacteria has been found to produce semiconducting nanotubes produced, which is a huge ste...
From Wikipedia: Lithification is a process of porosity destruction through compaction and cementatio...
“The Monsanto Company is a U.S.-based multinational agricultural biotechnology corporation. It...
bloombox So here it is, the now-famous (that was fast) Bloom “Box” Energy Servers...
Bacteria Aggregate and Tafoni Stone
Bacillus pasteurii is a “microorganism, readily available in marshes and wetlands, [that] soli...
Some inspiration from kokkugia… From the project Swarm Urbanism… “Agency operates...
BIO SmartBrief
California agency allots $50M for early-stage stem cell studies
The California Institute for Regenerative Medicine has allocated $50 million in funding for early-stage clinical trials of tr -More- ...
HGS and BioInvent form partnership to research antibodies
Human Genome Sciences will collaborate with BioInvent International to develop and market monoclonal antibodies for inflammat -More- The need for greater operational efficiency in clinical drug development is paramount. Organizations are increasingly turning to clinical trial management systems (CTMS) to improve trial efficiencies, cut trial costs, and enhance their productivity. Learn more...
Enhancing permeability of tumor vessels might improve drug delivery
U.S. -More- ...
Study: Stem cell in hair can turn into all types of skin cells
Dutch and Swedish scientists who studied mice said they discovered a type of stem cell in hair follicles that is capable of p -More- ...
Study notes increase in regulatory workload at biotech, drug firms
A study suggests that research and commercialization outsourcing caused a dramatic increase in regulatory-affairs workload at -More- ...
Feeling the pinch in today's market hurts
Let BIO ease your pain with BIO Business Solutions, BIO's cost-savings program, which provides products and services specific -More- ...
Colorado BioScience Association News Feed
Fitzsimons: From vacant Army post to medical promised land
There was a great multi-part feature in Sunday's Denver Post on the Fitzsimons Life Sciences District and Anschutz Medical Campus and how it "has emerged as an economic bright spot in the area, bringing advanced health care and research facilities to the region, garnering national attention, and providing an economic...
March 2 is the 2010 BioBeers Launch at Twisted Pine in Boulder
Kickoff the 2010 BioBeers Season at "BioBeers - Boulder" on March 2. BioBeers wonderful friends at the Twisted Pine will host (click for details & signup) Note: please arrive promptly at 6:30 p.m.This will be a special event with a chance to talk and connect with local life science leaders,...
Bioscience Day at the Capitol: Patrick Kelly, Biotechnology Industry Association, YouTube Now Posted
Patrick Kelly, vice president for state government relations and alliance development for the Biotechnology Industry Association, spoke about industry legislation at the federal level at the 2010 Bioscience Day at the Capitol.Location: Colorado State Capitol - January 27, 2010.This is the first of four parts.Link to the CBSA YouTube Channel...
CEO Collar leaves Colorado BioScience Association
From the Denver Business Journal:"John Collar has resigned as CEO and president of the Colorado BioScience Association, effective Feb. 1, according to an announcement sent to association members Friday morning.Denise Brown, the organization’s former top executive, will fill the position until a replacement is found."Link to the DBJ posting ...
Colorado BioScience Association's CEO moves on
From the Daily Camera - Feb 5, 2010:"John Collar, the chief executive officer and president of the Colorado BioScience Association, resigned this week to pursue other business opportunities, officials for the Denver-based organization said Friday.Collar headed the nonprofit association since December 2008.Officials named Denise Brown as the organization’s interim executive...
Archived from Jan 22, 2010 -- BioScience Day at Capitol to showcase industry Jan. 27
"The Colorado BioScience Association will host BioScience Day at the Capitol on Wednesday, Jan. 27, to highlight the bioscience advances made in the state and to learn about industry-related legislation likely to come up in the current session.The day will start at 7:30 a.m. with a networking breakfast at the...
About.com Biotech / Biomedical
Biotechnology Techniques for Tracing Food Pathogens
Dr. Shu Chen from the University of Guelph (Canada) presented this afternoon at the Annual North American Summit on Food Safety, describing her work on developing molecular methods for food safety and quality monitoring. There are several molecular methods for genotyping food pathogens and tracing them back to their source....
E. coli O157:H7 Duped by Built-in Food Safety Mechanism
The North American Summit on Food Safety starts tomorrow and I promised to tell the interesting story of how Dr. Rick Holley's laboratory is using applied food biotechnology to build safety into meat products. In a chain of events somewhat analogous to the activation of suicide genes in GMOs released...
Toronto (Canada) plays host next Tuesday and Wednesday to the 6th Annual North American Summit on Food Safety. Topics being covered include some very relevant issues in food biotechnology, such as pathogen management and building safety into food. A presentation on the latter, by Dr. Rick Holley (Dept. of Food...
Digital Education in the Sciences
I was recently asked about my thoughts on the ongoing shift to digital education and social media legitimacy as it pertains to science and biotechnology. It seems in the past 2 or so years, it isn't enough for a scientific journal to publish it's papers online, but, nearly each and...
We all have those moments, especially while at work doing the same mundane task day in and day out, where we wonder why we became scientists in the first place. Do you remember what fascinates you about science? MAKE magazine has created a webpage called The Elements of Humanity, that...
Epigenetic Markers Change with Age
During development of our bodies, when the cells of the blastocyst begin to differentiate into specialized forms to make various tissues, there are a number of epigenetic markers that determine what kind of tissue is formed. One of these markers is DNA methylation. Methylation patterns on our DNA change with...
Biology News Net
Opposing functions of a key molecule in the development of organisms
Scientists headed by ICREA researcher Marco Milán, at the Institute for Research in Biomedicine (IRB Barcelona), reveal a surprising new function of Notch protein that contrasts with the one known to date. Found in the cell membrane, this protein activates a signalling pathway that regulates the expression of genes that...
'Microtentacles' on tumor cells appear to play role in how breast cancer spreads
Researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center have discovered that "microtentacles," or extensions of the plasma membrane of breast cancer cells, appear to play a key role in how cancers spread to distant locations in the body. Targeting these microtentacles might prove to be a...
Phylogenetic analysis of Mexican cave scorpions suggests adaptation to caves is reversable
Blind scorpions that live in the stygian depths of caves are throwing light on a long-held assumption that specialized adaptations are irreversible evolutionary dead-ends. According to a new phylogenetic analysis of the family Typhlochactidae, scorpions currently living closer to the surface (under stones and in leaf litter) evolved independently on...
Carnegie Mellon researchers seek to control blood loss
Carnegie Mellon University's Matt Oberdier is developing a new hydrosurgery system to help physicians better manage excessive bleeding during surgery. ...
Why surprises temporarily blind us
Reading this story requires you to willfully pay attention to the sentences and to tune out nearby conversations, the radio and other distractions. But if a fire alarm sounded, your attention would be involuntarily snatched away from the story to the blaring sound. ...
More maize ethanol may boost greenhouse gas emissions
In the March issue of BioScience, researchers present a sophisticated new analysis of the effects of boosting use of maize-derived ethanol on greenhouse gas emissions. The study, conducted by Thomas W. Hertel of Purdue University and five co-authors, focuses on how mandated increases in production of the biofuel in the...
Terry Etherton Blog on Biotechnology
Global Status of GM Crops – 2009
The International Service for the Acquisition of Agri-biotech Applications (ISAAA) released their annual report on global adoption of genetically modified (GM) on February 23, 2010. An executive summary of Global Status of Commercialized Biotech/GM Crops: 2009 – The first fourteen years, 1996 to 2009 presents highlights of the amazing growth...
Chad Dechow Associate Professor, Dairy Cattle Genetics Department of Dairy and Animal Science The Pennsylvania State University “Instead of redesigning the factory farm to suit the animals, they are redesigning the animals to suit the factory farm” Matthew Scully. The American Conservative, May 23, 2005. My most memorably painful experience occurred when I was a teenage...
Not Grass-Fed, but at Least Pain-Free – An Experiment in Social Media
Terry D. Etherton The Opinion-Editorial published in the New York Times was passed along to me earlier today. As readers of Terry Etherton Blog on Biotechnology appreciate, I have written about a variety of topics across the landscape of science and agriculture; defending science, as well as attempting to counter attacks...
By Scott Kilman and Thomas Catan The Wall Street Journal Posted January 15, 2010 The U.S. Justice Department has opened a formal antitrust investigation into crop-biotechnology giant Monsanto Company as it contends with the loss of patent protection on its blockbuster soybean in 2014. Monsanto on Thursday received a formal demand from the Justice...
Big Concerns Regarding the PEW Report on Industrial Farm Animal Production
FASS Shares AVMA’s Concerns Regarding Pew Report on Industrial Farm Animal Production Posted January 5, 2010 The Federation of Animal Science Societies (FASS) has analyzed the Pew Commission on Industrial Farm Animal Production’s report Putting Meat on the Table: Industrial Farm Animal Production in America as well as the American Veterinary Medical...
Taking the “Human” out of “Humane”
A post from the Center for Consumer Freedom Posted January 5, 2010 We took a look last week at some details of the 2008 tax return filed by the deceptive Humane Society of the United States (HSUS). The filing shows that HSUS paid out less than one-half of one percent of its...
BMC Biotechnology - Latest Articles
Anti-tumor therapy with macroencapsulated endostatin producer cells.
Background: Theracyte is a polytetrafluoroethylene membrane macroencapsulation system designed to induce neovascularization at the tissue interface, protecting the cells from host's immune rejection, thereby circumventing the problem of limited half-life and variation in circulating levels. Endostatin is a potent inhibitor of angiogenesis and tumor growth. Continuous delivery of endostatin improves the...
Background: A tannic acid-inducible and mycoviral-regulated laccase3 (lac3) from the chestnut blight fungus Cryphonectria parasitica has recently been identified, but further characterization was hampered because of the precipitation of protein products by tannic acid supplementation. The present study investigated the heterologous expression of the functional laccase3 using a yeast Saccharomyces cerevisiae. Results: Laccase...
Background: The large serine recombinase phiC31 from broad host range Streptomyces temperate phage, catalyzes the site-specific recombination of two recognition sites that differ in sequence, typically known as attachment sites attB and attP. Previously, we characterized the phiC31 catalytic activity and modes of action in the fission yeast Schizosaccharomyces pombe. Results: In this...
Background: Molecular switch systems that activate gene expression by a small molecule are effective technologies that are widely used in applied biological research. Nuclear receptors are valuable candidates for these regulation systems due to their functional role as ligand activated transcription factors. Previously, our group engineered a variant of the retinoid...
Immunohistochemical detection of transgene expression in the brain using small epitope tags
Background: In vivo overexpression of proteins is a powerful approach to study their biological function, generate disease models or evaluate gene therapy approaches. In order to investigate an exogenously expressed protein, specific and sensitive detection is essential. Unfortunately, antibodies that allow histological detection of the protein of interest are not always...
Broad spectrum microarray for fingerprint-based bacterial species identification
Background: Microarrays are a powerful tool for DNA-based molecular diagnostics and identification of pathogens. Most target a limited range of organisms and are based on only one or very few genes for specific identification. Such microarrays are limited to organisms for which specific probes are available, and often have difficulty discriminating...
CropBiotech Update
Uganda launched the report on the Global Status of Commercialized Biotech /GM Crops: 2009 at the International Conference on Agrobiotechnology, Biosafety and Seed Systems in Developing Countries (AGBIOSAFESEED 2010), held at the Imperial Royal Hotel in Kampala on March 10, 2010. The four- day conference was attended by over...
Bayer and Mendel Biotech Collaborate on Crop Protection
Bayer CropScience and U.S.-based Mendel Biotechnology, Inc. have signed a three-year collaboration agreement to develop chemical products which make crops more resistant to biotic and abiotic stress factors, thus stabilizing yields and improving crop productivity. "Chemical products that mediate enhanced crop performance are an untapped market with......
Barroso Defends Transgenics and EFSA Scientists
Jose Manuel Barroso, the president of the European Commission, defended in Parliament the approval of genetically modified organisms (GMOs) based on the scientific evidence provided to him by the experts of the European Food Safety Authority (EFSA). The EU president expressed his opinion when he was criticized by the Green...
GIPB Presents National Plant Breeding Programs of 35 Countries
The Global Partnership Initiative for Plant Breeding Capacity Building (GIPB) announced the presentation of national plant breeding programs of 35 countries in the GIPB website. In each country folder, information is provided on the brief background of the country and its agriculture, presents the on-going plant breeding activities in each...
New Simple Biomass Process Yield Fermentable Sugars for Bioethanol
Research efforts on the production of biofuels through the use of inedible plant materials such as corn stover, switchgrass and wood chips across the United States have been a response to a federal mandate that biofuels and ethanol would not be derived from food sources. However, the plant's cellulose's energy-rich...
Seminar on Microbiology in Indonesia
A seminar of the Indonesian Society for Microbiology : Harnessing the power of microbes for better food, agro-industry, health, and environment will be held on on 4-7 October 2010 at IPB International Convention Center (IPBICC). The seminar aims to provide a platform for international microbiologists, biotechnologists, and bioinformaticians, policy......
biotechnology « WordPress.com Tag Feed
Engineering Biosensors: Kinetics and Design Applications
A. Sadana,«Engineering Biosensors: Kinetics and Design Applications» Academic Press | ISBN: 01261376...
So I’m reading a back issue of the New Yorker (I’m a busy girl, I get behind), and am in...
A COTO ANTHEM (lyrics under Read More link) The paranoia is in bloom, the PR transmissions will resu...
Centre for Cellular and Molecular Biology, invites applications from candidates who are bonafide Ind...
The leading business intelligence provider, has released its latest research, “Small and Medium Biop...
Nanofabrication Towards Biomedical Applications: Techniques, Tools, Applications, and Impact by Chal...
Biotech News
Genentech Provides Update On Phase III Study Of Avastin In Men With Late Stage Prostate Cancer
Genentech, Inc., a wholly owned member of the Roche Group , announced today the topline results of a Phase III trial led by the U.S. Cancer and Leukemia Group B and sponsored by the National Cancer Institute investigating the use of Avastin in combination with docetaxel chemotherapy and prednisone in...
Battelle, IBM, Merck join UPMC's effort to produce vaccines
The $8-billion non-profit integrated global health enterprise headquartered in Pittsburgh, Pennsylvania, UPMC, yesterday said that it has been joined by the world's largest independent researcher Battelle, IBM and Merck & Co Inc, in a first-of-its-kind initiative to establish a flexible vaccine development and production facility....
Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin
Generic pharmaceuticals provider Caraco Pharmaceutical Laboratories Ltd said on Thursday that the company has introduced 50mg and 100mg oxaliplatin injections....
Positive results from BioSante Pharmaceuticals' GVAX Leukemia vaccine human clinical study
BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia patients taking the drug Gleevec ....
Staff Photo by Dan Henry Minnnied Hyter, left, and Cassandra Lee watch for label quality as bottles of Selsun Blue pass by at the Chattem plant....
Pfizer Discontinues a Phase 3 Study of Figitumumab in Previously...
Mar 11, 2010 - Pfizer Inc. announced today the discontinuation of A4021018 , a Phase 3 trial examining the effects of investigational compound figitumumab in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced non-adenocarcinoma non-small cell lung cancer ....
Bio Job Blog
Direct-to-Consumer Advertising: Have We Got a Deal for You!
Medicis Pharmaceutical, the maker of Dysport a drug approved by the US Food and Drug Administration (FDA) to smooth skin furrows between the eyebrows, recently introduced a marketing campaign that offers people who use Dysport drug discounts and a patient satisfaction rebate guarantee. The campaign, which runs through April 30,...
Astra Zeneca Jumps on the Generic Drug Bandwagon
Astra Zeneca announced today that it has agreed to market 18 of Torrent Pharmaceuticals Ltd.’s branded generic drugs in 9 emerging markets, marking the U.K. drugmaker’s first generic-drug partnership. Unlike some its competitors, Astra Zeneca is very vulnerable to generic competition as many of its best selling products such as Nexium...
The Life Sciences Industry: China Begins to Turn Up the Heat
Until recently, there was little or no mention of business activity within the emerging Chinese life sciences industry. However, as the Chinese middle class continues to grow, the need and demand for pharmaceutical and biotechnology drugs (including vaccines and other biologics continues) to grow at a frenetic pace. Further, a...
Another Biotech Company Bites the Dust
Abbott Laboratories yesterday announced that it will buy Facet Biotech Corp. for about $450 million in cash. Facet, along with its development partner Biogen Idec, had planned on moving a potential monoclonal antibody (MAb) treatment for multiple sclerosis called daclizumab into late stage clinical development in the second quarter of...
Downsizing: Biotech Companies Are Catching Up to Big Pharma
For the past year or so, I have been focusing on the downsizing and layoffs taking place at big pharmaceutical companies. The unprecedented size and scope of these massive layoffs have overshadowed the downsizing and job loss taking place at small to mid-size public and private biopharmaceutical companies. In contrast with...
Why Five Years of Data Exclusivity Makes Sense for US Follow-on Biologics Legislation
In case you did not know, the 12 years of market exclusivity proposed for follow-on biologics by supporters and lobbyists for the pharmaceutical and biotechnology industries is part of the impending US healthcare reform legislation currently pending in Congress. While President Obama has publicly announced that he supports a five...
ScienceDaily: Biotechnology News
Genetic mapping of algae biofuel species groundwork done
Using green algae to produce hydrocarbon oil for biofuel production is nothing new; nature has been doing so for hundreds of millions of years, according a scientists....
Scientists solve puzzle of chickens that are half male and half female
A puzzle that has baffled scientists for centuries -- why some birds appear to be male on one side of the body and female on the other -- has been solved by researchers. The research, which involved studying rare naturally occurring chickens with white (male) plumage on one side and...
Discovery of an antibiotic's capacity to improve cell function in laboratory tests is providing movement disorder researchers with leads to more desirable molecules with potentially similar traits, according to scientists....
Development of more muscular trout could boost commercial aquaculture
A 10-year effort by a scientist to develop transgenic rainbow trout with enhanced muscle growth has yielded fish with what have been described as six-pack abs and muscular shoulders that could provide a boost to the commercial aquaculture industry....
Behavior of single protein observed in unprecedented detail
Scrutinizing a single molecule for more than a few milliseconds used to require effectively "stapling" it down, inhibiting its normal behavior. Now, using a newly developed technique, chemists have for the first time confined a protein (one involved in photosynthesis), observed its behavior for more than a second and learned...
Pancreatic cancer study reveals mechanism initiating disease, in mice
Scientists have discovered how a mutated gene known as Kras is able to hijack mouse cells damaged by acute pancreatitis, putting them on the path to becoming pancreatic cancer cells....
OnBioVC
OnBioVC | Welcome…New Feature Friday…Maybe?
Site traffic and subscribers have both been on the rise here at OnBioVC.com; we are both humbled and appreciative for this growth, and that is why now, it is important to listen to what the OnBioVC market desires as our growth trajectory is architected. To date content at OnBioVC.com has been...
OrbiMed | Looking for Some (More) of This?
The ‘Looking for Some (More) of This?’ series is focused upon the tracking of newly formed venture funds who are financing biomedical innovation. Whilst many continue to pound the drum echoing the sentiment that limited partners remain sidelined, here is additional demonstration of continued new capital formation in the life science...
OnBioVC | Thanks to Our Sponsors
OnBioVC would like to thank our sponsors, without whom complete coverage of the life science venture capital, M&A and IPO sector would not be possible: Freestone Group | Integrated Solutions for Emerging Life Science Companies MORE INFO AT: http://www.TheFreestoneGroup.com CONTACT: Jim Lewis jlewis@thefreestonegroup.com Regulus Pharmaceutical Consulting | Regulatory Affairs – Quality Assurance...
Nautilus Neurosciences, Inc.: Series A $14.5M
Nautilus Neurosciences (Bridgewater, NJ) near commercial-stage specialty neurology pharma focused on migraine and acute pain, closed a $14.5M Series A financing. Participants include Tailwind Capital. _________________________________________________________________________ NOTE: New OnBioVC Friday feature coming, well…this Friday!...
NABsys (Providence, RI) a development-stage company focused on polymerase-free solid-state electronic detection DNA sequencing free of amplification or labeling focused point-of-care clinical use, closed a $7M Series B financing. Participants include Stata Venture Partners and Point Judith Capital. _________________________________________________________________________ NOTE: New OnBioVC Friday feature coming, well…this Friday!...
Eleven Biotherapeutics, Inc.: Series A $35M
Eleven Biotherapeutics (Cambridge, MA) a preclinical-stage biopharmaceutical company focused on protein therapeutics for the treatment of inflammation and coagulation disorders, closed a $35M Series A financing. Participants include Flagship Ventures and Third Rock Ventures. _________________________________________________________________________ NOTE: New OnBioVC Friday feature coming, well…this Friday!...
FierceBiotech
HGS, BioInvent ink antibody deal
Human Genome Sciences and BioInvent International have inked a deal to discover, develop and commercialize therapeutic monoclonal antibodies that specifically target antigens discovered by HGS. BioInvent will use its antibody discovery technology to generate and develop monoclonal antibody candidates, with a focus on the field of inflammation. Financial terms were not disclosed. Release...
MiddleBrook plots major job cuts as CEO exits
MiddleBrook Pharmaceuticals' downward slide continues. In its full-year results release, the Westlake, TX-based company says it's eliminating its field sales force and significantly reducing its corporate staff to preserve money as it explores its options. As part of the cut-backs, CEO John Thievon will resign effective Monday, March 15, and...
Arena will launch lorcaserin with or without partner
Arena Pharmaceuticals expects to launch its weight loss drug lorcaserin within 12 weeks of FDA approval--with or without a partner, according to the company. The agency's deadline for review of the drug is Oct. 22. "We are pleased with the timely execution and significant progress made in our lorcaserin program," Jack Lief,...
Pfizer stops another figitumumab trial
Pfizer has discontinued another trial of its monoclonal antibody figitumumab. The drug was in a Phase III trial in combination with Tarceva as a second/third-line treatment for patients with previously treated advanced non-adenocarcinoma non-small cell lung cancer (NSCLC). An independent data safety monitoring committee recommended that Pfizer stop the study after...
Aveo proves investors still lack appetite for biotech IPOs
Anthera, Ironwood and Aveo. What do these developers have in common? With their debuts, they've all proven that despite hope for a resurgence of biotech IPOs after a ghastly 2009, investors still aren't eager to invest in risky companies. After delaying its debut two days, Aveo unloaded its initial public shares...
Genetix raises $35M to advance gene therapies
Cambridge, MA-based Genetix Pharmaceuticals has completed a $35 million Series B financing with new investors Third Rock Ventures and Genzyme Ventures joining TVM Capital, Forbion and Easton Capital. The company was founded in 1993, but in 2004 Genetix was re-started and recapitalized in a Series A investment by TVM, Forbion, and Easton,...
BioSpace.com Featured News and Stories
Movement Disorder Symptoms Are Lessened by an Antibiotic, University of Alabama at Birmingham Study
EurekAlert! -- TUSCALOOSA, Ala. Discovery of an antibiotic's capacity to improve cell function in laboratory tests is providing movement disorder researchers with leads to more desirable molecules with potentially similar traits, according to University of Alabama scientists co-authoring a paper publishing March 10 in the journal Disease Models &...
Pfizer Inc. Says Sutent Breast Cancer Trials Fail
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that two Phase 3 studies of Sutent (sunitinib malate) in advanced breast cancer did not meet their primary endpoints. The SUN 1064 Phase 3 study of sunitinib in combination with docetaxel for the first-line treatment of patients with advanced HER-2 negative breast cancer did...
WOODCLIFF LAKE, N.J., March 11 /PRNewswire-FirstCall/ -- Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood...
Women On Pill 'May Live Longer', Aberdeen University Study
LONDON (Reuters) - One of the world's largest studies of the contraceptive pill has found that women who have taken it can expect longer lives and are less likely to die from any cause, including cancer and heart disease....
ScienceDaily (Mar. 11, 2010) A clinical research trial of a new treatment to restore brain cells damaged by stroke has passed an important safety stage, according to the UC Irvine neurologist who led the effort....
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today the discontinuation of A4021018 (also known as ADVIGO 1018), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced non-adenocarcinoma non-small cell lung cancer (NSCLC). An independent Data...
Bioresearch Online Products
BioStack Twister II Microplate Handler
The BioStack™ Twister® II is a scalable robotic arm that can be interfaced to one or more BioTek readers, washers and liquid handling systems with incremental storage capabilities and automation for entire work cells....
MicroFill™ Microplate Dispenser
The MicroFill™ Microplate Dispenser accommodates 96-, 384- and 24-well standard microplates and deep well blocks for bulk reagent dispensing applications....
Whether you are evaluating conventional stainless steel or single-use bioreactor systems, every bioreactor system must accomplish the same thing: control a bioprocess for an intended result. The result may be biomass, product titer, substrate conversion or any number of complex, process-specific productivity measures....
Zeta Plus EXT ZA Series Depth Filters
Filters- The new Zeta Plus EXT filters EXTends depth filtration capacity and EXTends protection of downstream membranes thereby EXTending filter life and lowering overall filtration costs. Zeta Plus EXT Series is a family of advanced dual zone depth filters designed to provide optimal clarification of bioprocess, biological and pharmaceutical fluids....
Synergy H4 Hybrid Microplate Reader
SynergyT H4 with Hybrid TechnologyT is a patent-pending multi-mode detector that combines the optical systems of Synergy Mx and Synergy 2 in one compact instrument. It is the ideal instrument for research and drug discovery applications when having to choose between flexibility and performance is not an option....
Warehouse Services by Cherokee Pharmaceuticals LLC...
Biotech Blog
Do you work in biotechnology? Live in the DC area? Join DC Biotech!
Copyright © BiotechBlog, partner of DrugPatentWatch, and a product of thinkBiotech DC Biotech is an informal networking group in the DC area. A discussion forum is hosted on LinkedIn, and regular happy hours are held in the DC area....
Educating the Next Generation of Biotechnology Managers and Founders
Copyright © BiotechBlog, partner of DrugPatentWatch, and a product of thinkBiotech I recently gave a talk on educating the next generation of biotechnology managers and founders at a biotechnology education workshop. My sense is that the traditional education paths are not ideal ways to prepare individuals to manage or start biotechnology...
Drug Patent Expirations in March 2010
Copyright © BiotechBlog.com, a product of thinkBiotech.com Drug Patent Expirations in March 2010 *Drugs may be covered by multiple patentsTradename Applicant Generic Name Patent Number Patent ExpirationAZASITE Inspire azithromycin 5,192,535 Mar 9, 2010SOLAGE Stiefel Labs Inc mequinol; tretinoin 5,470,567 Mar 19, 2010PYLERA Axcan Scandipharm bismuth subcitrate potassium; metronidazole; tetracycline 5,476,669 Mar 23, 2010KADIAN Actavis Elizabeth morphine sulfate 5,378,474 Mar 23, 2010PYLERA Axcan Scandipharm bismuth subcitrate potassium; metronidazole; tetracycline 5,196,205 Mar...
My picks for the Biotech Humantarian Award
Copyright © BiotechBlog.com, a product of thinkBiotech.com The judging is underway for the Biotech Humanitarian Award. The pool of nominees was divided between the judges, so I’ve only seen some of them, but I’ve made my selections. One of the elements I’ve been looking for is evidence of going beyond one’s...
Educating the Next Generation of Biotechnology Founders and Managers
Copyright © BiotechBlog.com, a product of thinkBiotech.com I will be giving a talk on Educating the Next Generation of Biotechnology Founders and Managers at Pittcon in Orlando on March 1st. The talk will be based on my observations in writing Building Biotechnology and editing Best Practices in Biotechnology Education, in addition to...
Drug Patent Expirations in February 2010
Copyright © BiotechBlog.com, a product of thinkBiotech.com Drug Patent Expirations in February 2010 *Drugs may be covered by multiple patentsTradename Applicant Generic Name Patent Number Patent ExpirationZAGAM Mylan sparfloxacin 4,795,751 Feb 4, 2010TEVETEN Abbott eprosartan mesylate 5,185,351 Feb 9, 2010MYOVIEW Ge Healthcare technetium tc-99m tetrofosmin kit 5,045,302 Feb 9, 2010TEVETEN HCT Abbott eprosartan mesylate; hydrochlorothiazide 5,185,351 Feb 9, 2010HYZAAR Merck hydrochlorothiazide; losartan potassium 5,138,069*PED Feb 11, 2010COZAAR Merck losartan potassium 5,138,069*PED Feb 11, 2010EXUBERA Pfizer insulin recombinant human RE37872 Feb 12, 2010EXUBERA Pfizer insulin recombinant human RE38385 Feb...
<< 1 >>